The CD36, CD105, and CD71 from Tube 3 were ranked by Compass-based analysis (Infinicyt) among the discriminating markers between AML blasts and normal myHPCs (Figures 1–4A). This evidence concerns the gene CD36 and acute myeloid leukemia.